Djordje Atanackovic

10PUBLICATIONS
47CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cellular immunologyMolecular medicineInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Apr 22, 2026
Preventing trogocytosis by cathepsin B inhibition augments CAR T-cell function.

|Aug 06, 2025
A novel sweeping antibody exhibits efficient clearance of the cancer- and autoimmunity-associated cytokine interleukin 16.

Jillian M Baker, Alexander Wang, Kenneth A Dietze

|Jul 03, 2025
Immune correlates of anti-BCMA CAR-T products idecabtagene vicleucel and ciltacabtagene autoleucel in a real-world cohort of patients with multiple myeloma.

Djordje Atanackovic, Tim Luetkens, Dina Schneider

|Mar 15, 2025
Universal driving restrictions beyond 4 weeks appear unnecessary following CAR-T therapy in multiple myeloma.

Rahul Banerjee, Alicia Richards, Shonali Midha

|Oct 04, 2024
Safety and efficacy of standard-of-care ciltacabtagene autoleucel for relapsed/refractory multiple myeloma.

Surbhi Sidana, Krina K Patel, Lauren C Peres

|Jul 26, 2024
Coordinated antiviral immune response in a patient with myeloma and systemic adenovirus infection post-BCMA CAR T cells.

Mehmet H Kocoglu, Tim Luetkens, Jacqueline T Bork

Pageof 2

Frequent Collaborators

7 joint publications

Tim Luetkens

5 joint publications

Kenneth A Dietze

4 joint publications

Kim Hankey

4 joint publications

Xiaoxuan Fan